Literature DB >> 7199669

Beneficial effects of lisuride in Meige disease.

F Micheli, M M Fernández Pardal, R C Leiguarda.   

Abstract

We studied the therapeutic effects of apomorphine, bromocriptine, and lisuride on the dystonic spasms of two patients with Meige disease. Lisuride, a potent dopamine receptor agonist, and apomorphine had equal efficacy in lessening facial dyskinesia, while bromocriptine had no consistent effect. Lisuride can be an excellent drug in the treatment of this disabling disorder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7199669     DOI: 10.1212/wnl.32.4.432

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Levodopa induced chorea in Meige syndrome.

Authors:  R J Hardie; A J Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

2.  Meige's syndrome associated with spasmodic dysphagia.

Authors:  R Kakigi; H Shibasaki; Y Kuroda; T Shin; T Maeyama; S Oono
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

Review 3.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

Review 4.  Clinical variants of idiopathic torsion dystonia.

Authors:  S Fahn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

5.  Blepharospasm: a review of 264 patients.

Authors:  F Grandas; J Elston; N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

6.  Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice.

Authors:  Xueliang Fan; Yuping Donsante; H A Jinnah; Ellen J Hess
Journal:  J Pharmacol Exp Ther       Date:  2018-01-18       Impact factor: 4.030

7.  Meige syndrome: double-blind crossover study of sodium valproate.

Authors:  J W Snoek; T W van Weerden; A W Teelken; W van den Burg; J P Lakke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.